UV

Uppada Venkataramana Anandareddy

Active Director Director DIN 10048544
DIN 10048544 First appointment Jan 2023 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Uppada Venkataramana Anandareddy

Data last updated:

Uppada Venkataramana Anandareddy is a Director at Mediflex Pharma Private Limited (since 2023). The company operates in Trading.

DIN 10048544
Primary Designation Director
Industry Trading
First Appointment 23 Jan 2023
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mediflex Pharma Private Limited U51909AP2021PTC118582
Director23 Jan 20232021Active

Board colleagues of Uppada Venkataramana Anandareddy

NameDINCompanyDesignation
Geethika Rajana09209369Mediflex Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mediflex Pharma Private Limited
Premium access

Shareholding and investment profile for Uppada Venkataramana Anandareddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uppada Venkataramana Anandareddy

Uppada Venkataramana Anandareddy currently holds 1 directorship: Mediflex Pharma Private Limited (Director, since 23 Jan 2023).

Uppada Venkataramana Anandareddy was first appointed on 23 Jan 2023 as Director at Mediflex Pharma Private Limited.

The current boards of Uppada Venkataramana Anandareddy's companies include Geethika Rajana (Mediflex Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available